Prostate Cancer - Results from #23200

AUA 2013 - Session Highlights: Intermittent docetaxel therapy for metastatic prostate cancer. A new paradigm? May 14, 2013

AUA 2013 - Session Highlights: Intermittent androgen ablation for advanced prostate cancer: Pooled analysis from randomized prospective trials May 14, 2013

AUA 2013 - Session Highlights: Long-term quality-of-life data from CAPSURE for men with localized prostate cancer May 14, 2013

Intratumoral inflammation is associated with more aggressive prostate cancer - Abstract May 14, 2013

Pathological outcomes of Japanese men eligible for active surveillance after radical prostatectomy - Abstract May 14, 2013

The management of prostate cancer: A retrospective chart review in 808 French men undergoing biopsy - Abstract May 14, 2013

Bilateral nerve sparing robotic-assisted radical prostatectomy is associated with faster continence recovery but not with erectile function recovery compared with retropubic open prostatectomy: The need for accurate selection of patients - Abstract May 14, 2013

Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer - Abstract May 14, 2013

Proton beam radiation therapy for prostate cancer-Is the hype (and the cost) justified? - Abstract May 14, 2013

AUA 2013 - Session Highlights: Abiraterone shows improvement in quality of life outcomes at > 2 years of follow-up May 14, 2013

AUA 2013 - Session Highlights: Revisiting FDG-PET/CT in the primary staging of high risk prostate cancers before local therapies May 14, 2013

AUA 2013 - Session Highlights: Utility of salvage lymph node dissection in men with recurrent prostate cancer following local therapy May 14, 2013

AUA 2013 - Session Highlights: Performance of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy May 13, 2013

AUA 2013 - Session Highlights: Employing the epigenetic field effect to detect prostate cancer in biopsy-negative patients May 13, 2013

AUA 2013 - Session Highlights: Development and validation of the biopsy-based genomic prostate score (GPS) as a predictor of high grade or extracapsular prostate cancer to improve patient selection for active surveillance May 13, 2013

Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning - Abstract May 13, 2013

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer - Abstract May 13, 2013

Three-dimensional summation of rectal doses in brachytherapy combined with external beam radiotherapy for prostate cancer - Abstract May 13, 2013

AUA 2013 - Video Presentation: Treatment practice patterns in metastatic castration-resistant prostate cancer (mCRPC) patients prior to receiving sipuleucel-T: Data from PROCEED May 13, 2013

Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: Results from a multi-institutional phase 1 study - Abstract May 13, 2013

Page 1161 of 1435